FBIN CEO Jesse Singh Buys $996K in Shares in Cluster Deal

SEC Form 4 filing document showing insider stock purchase details for Fortune Brands Innovations CEO Jesse Singh

Fortune Brands Innovations, Inc. (NYSE: FBIN) disclosed a fresh round of insider buying this week, with Chief Executive Officer Jesse G. Singh adding a substantial block of shares to his personal holdings, according to a Form 4 filed with the SEC. On August 7, 2026, Singh purchased 19,560 shares of FBIN on the open market … Read more

Foresite Capital Buys $2.52M of Latigo Biotherapeutics (LTGO) Stock

SEC Form 4 filing showing Foresite Capital Management's purchase of Latigo Biotherapeutics shares

Foresite Capital Management V, LLC, a 10%+ owner of Latigo Biotherapeutics, Inc. (LTGO), disclosed an open-market purchase of 140,000 shares on August 10, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The shares were bought at $18.00 apiece, for a total transaction value of $2,520,000.00. This was a straightforward open-market … Read more

Prescott Group’s 13-Buy Cluster Lifts NATR Stake to $2.3M

Chart-style graphic showing a cluster of insider stock purchases in Natures Sunshine Products (NATR) over five trading days

Prescott Group Capital Management, L.L.C., a 10%+ owner of Natures Sunshine Products Inc (NATR), disclosed another open-market purchase of the company’s shares in a Form 4 filing. On August 10, 2026, the firm bought 876 shares at $15.64 apiece, a purchase worth $13,700.64. Following the transaction, Prescott Group’s indirect holdings — shares held through a … Read more

ATTO: venBio Buys $6.5M in Attovia Therapeutics Stock

SEC Form 4 insider trading disclosure showing venBio Global Strategic Fund IV's purchase of Attovia Therapeutics shares

Attovia Therapeutics, Inc. (ATTO) has another notable name on its insider buying ledger. venBio Global Strategic Fund IV, L.P., listed as an insider of the company, purchased 382,352 shares on the open market on August 6, 2026, at a price of $17.00 per share. The transaction totaled $6,499,984.00, funded directly by the fund rather than … Read more

COE CEO Huang Adds $3M More, Spree Tops $29.4M

SEC Form 4 filing showing insider stock purchase details for 51Talk Online Education Group CEO

51Talk Online Education Group (NYSE: COE) disclosed another insider purchase from its top executive, extending a buying pattern that has now stretched across more than a week. According to a Form 4 filing, Huang Jack Jiajia, who serves as Chief Executive Officer, Director, and a 10%+ owner of the company, bought 158,460 shares on August … Read more

Latigo Biotherapeutics (LTGO) Insider Buys $2.52M in Shares

SEC Form 4 filing document showing an insider stock purchase at Latigo Biotherapeutics

A newly filed Form 4 shows James B. Tananbaum, an insider at Latigo Biotherapeutics, Inc. (LTGO), purchased 140,000 shares of the company on the open market on August 10, 2026. The transaction was executed at $18.00 per share, for a total outlay of $2,520,000.00 out of the insider’s own funds. Unlike option exercises or grants … Read more

APCX Director Lord Buys More Shares as Cluster Hits $115.9M

SEC Form 4 filing details showing an insider stock purchase at AppTech Payments Corp.

AppTech Payments Corp. (APCX) director Albert L. Lord disclosed another open-market purchase in a Form 4 filing, adding to a buying pattern that has drawn attention from insider-trading trackers over the past week. According to the filing, Lord purchased 20,000 shares on August 7, 2026, at a price of $0.40 per share, for a total … Read more

ABTC Insider Mateen Justin Buys $1M in Cluster Buy

SEC Form 4 filing document showing insider stock purchase details for American Bitcoin Corp

A fresh Form 4 filing shows Mateen Justin, an insider at American Bitcoin Corp. (ABTC), purchased 162,438 shares of the company on the open market on August 6, 2026. The transaction was executed at $6.19 per share, for a total outlay of $1,005,052.64 paid from personal funds. Following the purchase, Justin’s directly held stake in … Read more

MA Eagle II Buys $10M of SCISX Shares at $24.71 Each

SEC Form 4 filing document showing an insider stock purchase for MA Specialty Credit Income Fund (SCISX)

A newly filed Form 4 shows MA Eagle II Holdings Fund, listed as an insider of MA Specialty Credit Income Fund (SCISX), made a sizable open-market purchase of the fund’s shares. The transaction, dated August 6, 2026, involved 404,694 shares acquired at $24.71 apiece, for a total outlay of $10,000,000.01. This was not a grant, … Read more

Forbion Buys $34.6M of Braveheart Bio (BRVE) Stock

Chart showing insider cluster stock purchase activity for Braveheart Bio (BRVE)

A new Form 4 filing shows Forbion Growth Opportunities Fund III Cooperatief U.A., listed as an insider of Braveheart Bio, Inc. (BRVE), purchased 1,920,000 shares of the company on August 7, 2026. The shares were bought on the open market at $18.00 apiece, for a total outlay of $34,560,000.00. Following the purchase, the fund’s directly … Read more

ATTO: Sanofi Buys $5.1M in Attovia Therapeutics Shares

SEC Form 4 filing showing Sanofi's insider stock purchase in Attovia Therapeutics (ATTO)

Sanofi has disclosed a substantial open-market purchase of shares in Attovia Therapeutics, Inc. (ATTO), according to a Form 4 filed with the SEC. The filing shows Sanofi bought 300,000 shares on August 6, 2026 at a price of $17.00 per share, a transaction valued at $5,100,000.00. Following the purchase, Sanofi’s stake in Attovia stands at … Read more

ATTO: Redmile Group Buys $3.4M in Attovia Amid Cluster Buying

Chart showing insider stock purchase activity at Attovia Therapeutics (ATTO) in August 2026

Attovia Therapeutics, Inc. (NASDAQ: ATTO) is showing a fresh cluster of insider buying, with Redmile Group, LLC — a 10%+ owner of the company — disclosing an open-market purchase of 200,000 shares at $17.00 per share on August 6, 2026. The transaction, filed on Form 4, totaled $3,400,000 and brings Redmile Group’s directly held stake … Read more